Commentary: Early Secondary Prevention of Cardioembolic Stroke with Direct Oral Anticoagulants (DOAC)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Journal of Neurology & Neuromedicine 2.3 (2017): S. 12-14.
- Keyword
-
-
Hirngefäßkrankheit
Schlaganfall
Hirninfarkt
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2017
- Creator
- URN
-
urn:nbn:de:bvb:29-opus4-95348
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Macha, Kosmas
- Volbers, Bastian
- Kallmünzer, Bernd
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2017
Other Objects (12)
Adherence to oral anticoagulant therapy in secondary stroke prevention - impact of the novel oral anticoagulants
Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines
Antiplatelets or anticoagulants? Secondary prevention in cervical artery dissection: an updated meta-analysis
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
Secondary prevention after ischaemic stroke: the ASPIRE-S study
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
Personalized approach to primary and secondary prevention of ischemic stroke
Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke
Stroke Prevention with Oral Anticoagulants: Summary of the Evidence and Efficacy Measures as an Aid to Treatment Choices
Adherence to oral anticoagulant therapy in secondary stroke prevention - impact of the novel oral anticoagulants
Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines
Antiplatelets or anticoagulants? Secondary prevention in cervical artery dissection: an updated meta-analysis
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
Secondary prevention after ischaemic stroke: the ASPIRE-S study
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
Personalized approach to primary and secondary prevention of ischemic stroke
Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke
Stroke Prevention with Oral Anticoagulants: Summary of the Evidence and Efficacy Measures as an Aid to Treatment Choices
Adherence to oral anticoagulant therapy in secondary stroke prevention - impact of the novel oral anticoagulants
Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Anticoagulants for stroke prevention in heart failure with reduced ejection fraction
Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines
Antiplatelets or anticoagulants? Secondary prevention in cervical artery dissection: an updated meta-analysis
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
Secondary prevention after ischaemic stroke: the ASPIRE-S study
Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants
Personalized approach to primary and secondary prevention of ischemic stroke
Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke